Transcriptomic and network analyses identify epigenetic regulators of drug-tolerant persister (DTP) subsets in EGFR-mutant HCC827 non-small cell lung cancer
Genes & Genomics · 2026-11 · 48 (11) · 1369-1382
DOI: 10.1007/s13258-026-01801-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Genomics, online erschienen am 15.09.2026. Verfasst von JuneKyu Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, College of Life Sciences, Konkuk University, Seoul, 05029, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Epigenesis, Genetic, Lung Neoplasms, Acrylamides. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
BACKGROUND: The clinical efficacy of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), in EGFR-mutant non-small cell lung cancer (NSCLC) is limited by the inevitable acquired resistance. Drug-tolerant persister (DTP) cells, which survive initial therapy, are considered a key reservoir for this resistance. Understanding the molecular characteristics of DTPs is essential for developing strategies to prevent relapse. OBJECTIVE: This study aimed to characterize the transcriptomic landscape of osimertinib-tolerant DTP cells and identify key epigenetic regulators associated with the DTP phenotype in EGFR-mutant HCC827 NSCLC cells through integrated transcriptomic and network analyses. METHODS: We established an in vitro model of osimertinib tolerance using an EGFR-mutant (exon 19 deletion) HCC827 NSCLC cell line. Parental HCC827 cells and DTP subsets were subjected to transcriptomic analysis by RNA sequencing (RNA-seq). Differentially expressed genes were identified, followed by bioinformatics analyses, including Gene Ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and protein-protein interaction (PPI) network analyses to identify key biological processes driving the DTP phenotype. Key findings were validated using quantitative real-time PCR (qPCR). RESULTS: Osimertinib treatment induced a morphologically distinct DTP population. Transcriptomic profiling revealed a marked shift in gene expression compared to parental cells. Functional enrichment analysis showed significant upregulation of epigenetic pathways. PPI network analysis identified a core module of eight hub genes, including histone deacetylases (HDAC5, HDAC9), sirtuins (SIRT1, SIRT2), and histone acetyltransferase (KAT2B). qPCR confirmed increased expression of HDAC5, HDAC9, and SIRT1. CONCLUSION: Epigenetic reprogramming accompanies the transition to an osimertinib-tolerant state in EGFR-mutant HCC827 cells. Targeting HDACs and sirtuins may represent a promising strategy to eliminate DTP subpopulations and delay or prevent acquired resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, College of Life Sciences, Konkuk University, Seoul, 05029, Republic of Korea.
- Department of Biological Sciences, College of Life Sciences, Konkuk University, Seoul, 05029, Republic of Korea. shinsy@konkuk.ac.kr.
- Cancer and Metabolism Institute, Konkuk University, Seoul, 05029, Republic of Korea. shinsy@konkuk.ac.kr.
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Han, J., Jung, E., & Shin, S. Y. (2026). Transcriptomic and network analyses identify epigenetic regulators of drug-tolerant persister (DTP) subsets in EGFR-mutant HCC827 non-small cell lung cancer. Genes & Genomics, 48(11), 1369-1382. https://doi.org/10.1007/s13258-026-01801-8
Vancouver
Han J, Jung E, Shin SY. Transcriptomic and network analyses identify epigenetic regulators of drug-tolerant persister (DTP) subsets in EGFR-mutant HCC827 non-small cell lung cancer. Genes & Genomics. 2026;48(11):1369-1382. doi:10.1007/s13258-026-01801-8
BibTeX
@article{Han2026,
author = {Han, JuneKyu and Jung, Euitaek and Shin, Soon Young},
title = {Transcriptomic and network analyses identify epigenetic regulators of drug-tolerant persister (DTP) subsets in EGFR-mutant HCC827 non-small cell lung cancer},
journal = {Genes & Genomics},
year = {2026},
volume = {48},
number = {11},
pages = {1369--1382},
doi = {10.1007/s13258-026-01801-8}
}
EUVIMED